- Issue: 15 HEADLINES Sitagliptin add on to stable insulin therapy is well tolerated and improved Glycemic control Addition of sitagliptin enabled a greater proportion of patients to achieve the HbAlc target <7.0% For more information click on the below link - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415484/pdf/JDI-8-321.pdf An Academic initiative from Micro labs - Sitanorm-D Sitanorm-M Sitanorm (Sitagliptin 50/100 mg+ Dapagliflozin 5110mg Tablets) (Sitagliptin 50/100 mg+ Metformin 500/1000 mg SR Tablets) (Sitagliptin 25/50/100 mg Tablets)
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-